294 related articles for article (PubMed ID: 25127260)
1. Ipilimumab treatment associated pituitary hypophysitis: clinical presentation and imaging diagnosis.
Chodakiewitz Y; Brown S; Boxerman JL; Brody JM; Rogg JM
Clin Neurol Neurosurg; 2014 Oct; 125():125-30. PubMed ID: 25127260
[TBL] [Abstract][Full Text] [Related]
2. Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma.
Faje AT; Sullivan R; Lawrence D; Tritos NA; Fadden R; Klibanski A; Nachtigall L
J Clin Endocrinol Metab; 2014 Nov; 99(11):4078-85. PubMed ID: 25078147
[TBL] [Abstract][Full Text] [Related]
3. Ipilimumab-induced hypophysitis in melanoma patients: an Australian case series.
Lam T; Chan MM; Sweeting AN; De Sousa SM; Clements A; Carlino MS; Long GV; Tonks K; Chua E; Kefford RF; Chipps DR
Intern Med J; 2015 Oct; 45(10):1066-73. PubMed ID: 26010858
[TBL] [Abstract][Full Text] [Related]
4. Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review.
Juszczak A; Gupta A; Karavitaki N; Middleton MR; Grossman AB
Eur J Endocrinol; 2012 Jul; 167(1):1-5. PubMed ID: 22495490
[TBL] [Abstract][Full Text] [Related]
5. Hypophysitis and other autoimmune complications related to immune checkpoints inhibitors´ treatment: Spectrum of imaging appearances.
Malikova H; Holesta M; Fialova A; Arenbergerova M; Weichet J
Neuro Endocrinol Lett; 2018 Sep; 39(3):196-204. PubMed ID: 30431741
[TBL] [Abstract][Full Text] [Related]
6. Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma.
Okano Y; Satoh T; Horiguchi K; Toyoda M; Osaki A; Matsumoto S; Tomaru T; Nakajima Y; Ishii S; Ozawa A; Shibusawa N; Shimada T; Higuchi T; Chikamatsu K; Yamada M
Endocr J; 2016 Oct; 63(10):905-912. PubMed ID: 27440480
[TBL] [Abstract][Full Text] [Related]
7. First male case of lymphocytic hypophysitis in Korea.
Chung HK; Kim DH; Kim SJ; Park BJ; Kim EJ; Myong NH; Choi SJ
J Korean Med Sci; 2003 Apr; 18(2):290-4. PubMed ID: 12692433
[TBL] [Abstract][Full Text] [Related]
8. How reliably can autoimmune hypophysitis be diagnosed without pituitary biopsy.
Howlett TA; Levy MJ; Robertson IJ
Clin Endocrinol (Oxf); 2010 Jul; 73(1):18-21. PubMed ID: 20039888
[TBL] [Abstract][Full Text] [Related]
9. Ipilimumab cystic hypophysitis mimicking metastatic melanoma.
Wallace J; Krupa M; Brennan J; Mihlon F
Radiol Case Rep; 2018 Jun; 13(3):740-742. PubMed ID: 29977435
[TBL] [Abstract][Full Text] [Related]
10. Ipilimumab-induced hypophysitis: review of the literature.
Araujo PB; Coelho MC; Arruda M; Gadelha MR; Neto LV
J Endocrinol Invest; 2015 Nov; 38(11):1159-66. PubMed ID: 25957829
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab.
Brilli L; Danielli R; Ciuoli C; Calabrò L; Di Giacomo AM; Cerase A; Paffetti P; Sestini F; Porcelli B; Maio M; Pacini F
Endocrine; 2017 Dec; 58(3):535-541. PubMed ID: 28401443
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma.
Albarel F; Gaudy C; Castinetti F; Carré T; Morange I; Conte-Devolx B; Grob JJ; Brue T
Eur J Endocrinol; 2015 Feb; 172(2):195-204. PubMed ID: 25416723
[TBL] [Abstract][Full Text] [Related]
13. Lymphocytic hypophysitis.
Cauley K; Dalal A; Olson B; Onyiuke H
Conn Med; 2005 Mar; 69(3):143-6. PubMed ID: 15862000
[TBL] [Abstract][Full Text] [Related]
14. Pituitary enlargement following ipilimumab without long term endocrine dysfunction.
Nogueira E; Menon A; Dede A; Mitra I; Brock C; Larkin J; Morganstein D
Curr Probl Cancer; 2021 Dec; 45(6):100710. PubMed ID: 33622518
[TBL] [Abstract][Full Text] [Related]
15. [Lymphocytic hypophysitis: a report of 3 cases].
Lü ZH; Lu JM; Jin WS; Dou JT; Mu YM; Pan CY
Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):446-9. PubMed ID: 16008860
[TBL] [Abstract][Full Text] [Related]
16. Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody.
Iwama S; De Remigis A; Callahan MK; Slovin SF; Wolchok JD; Caturegli P
Sci Transl Med; 2014 Apr; 6(230):230ra45. PubMed ID: 24695685
[TBL] [Abstract][Full Text] [Related]
17. Lymphocytic hypophysitis in children: a novel presentation and literature review.
Kalra AA; Riel-Romero RM; Gonzalez-Toledo E
J Child Neurol; 2011 Jan; 26(1):87-94. PubMed ID: 21212455
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune hypophysitis may eventually become empty sella.
Gao H; Gu YY; Qiu MC
Neuro Endocrinol Lett; 2013; 34(2):102-6. PubMed ID: 23645305
[TBL] [Abstract][Full Text] [Related]
19. Ipilimumab-Induced Autoimmune Hypophysitis: Diagnostic and Management Challenges Illustrated by a Clinical Case.
Marques P; Grossman A
Acta Med Port; 2015; 28(6):775-9. PubMed ID: 27265913
[TBL] [Abstract][Full Text] [Related]
20. Lymphocytic hypophysitis in males.
Hindocha A; Chaudhary BR; Kearney T; Pal P; Gnanalingham K
J Clin Neurosci; 2013 May; 20(5):743-5. PubMed ID: 23485405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
